BJDX BLUEJAY DIAGNOSTICS INC Delisting Actions 8-K Filing 2024 - Nasdaq Compliance Bluejay Diagnostics, Inc. has regained compliance with Nasdaq listing rules as its stock price has been above $1.00 per share, closing a previous deficiency issue.Get access to all SEC 8-K filings of the BLUEJAY DIAGNOSTICS INC